allulose as a glp 1 GLP-1 Release by Rare Sugar D-Allulose Ameliorates Sucrose-Induced Obesity and Glucose Intolerance in Ovariectomized Mice 2026 Allulose Review: What It

Weight-loss programs that take a whole-person approach including pharmaceutical, clinical and behavioral support can be more effective at treating all aspects of a persons health

This can raise concerns about symptom return or weight regain

Maisa Feghali discussed GLP-1 use in women of child-bearing age and the current data available about their use in pregnancy

Compounded Formulations Gaining Traction in Dermatology Beyond peptides, several categories of compounded dermatology formulations are seeing increased prescriber interest heading into AAD 2026

Anyone committing to a six-month or twelve-month program through any compounded GLP-1 platform - WellMedr included - should ask the platform directly about its contingency plan if compounding availability narrows